Related content

New in silico and conventional in vitro approaches to advance HIV drug discovery and design

By Maga Giovanni   Veljkovic Nevena   Crespan Emmanuele   Spadari Silvio   Prljic Jelena   Perovic Vladimir   Glisic Sanja   Veljkovic Veljko  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 1, 2013-01 ,pp. : 83-92

Informa Healthcare

Access to resources Recommend Favorite

Integration of in silico and in vitro platforms for pharmacokinetic–pharmacodynamic modeling

By Sung Jong Hwan   Esch Mandy B   Shuler Michael L  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 9, 2010-09 ,pp. : 1063-1081

Informa Healthcare

Access to resources Recommend Favorite

Substrate selectivity of human intestinal UDP-glucuronosyltransferases (UGTs): in silico and in vitro insights

By Tripathi Satya Prakash   Bhadauriya Anuseema   Patil Abhijeet   Sangamwar Abhay T.  

Drug Metabolism Reviews, Vol. 45, Iss. 2, 2013-05 ,pp. : 231-252

Informa Healthcare

Access to resources Recommend Favorite

In Vitro, In Vivo, and In Silico Evaluation of the Bioresponsive Behavior of an Intelligent Intraocular Implant

By du Toit Lisa   Carmichael Trevor   Govender Thirumala   Kumar Pradeep   Choonara Yahya   Pillay Viness  

Pharmaceutical Research, Vol. 31, Iss. 3, 2014-03 ,pp. : 607-634

Springer Publishing Company

Access to resources Recommend Favorite

In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions

By Karlgren Maria   Ahlin Gustav   Bergström Christel   Svensson Richard   Palm Johan   Artursson Per  

Pharmaceutical Research, Vol. 29, Iss. 2, 2012-02 ,pp. : 411-426

Springer Publishing Company

Access to resources Recommend Favorite